- Home
- SCNX vs MTNB Comparison
SCNX vs MTNB Comparison
Compare SCNX & MTNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCNX
- MTNB
- Stock Information
- Founded
- SCNX 2010
- MTNB 2013
- Country
- SCNX United States
- MTNB United States
- Employees
- SCNX N/A
- MTNB N/A
- Industry
- SCNX Other Pharmaceuticals
- MTNB Biotechnology: Pharmaceutical Preparations
- Sector
- SCNX Health Care
- MTNB Health Care
- Exchange
- SCNX Nasdaq
- MTNB Nasdaq
- Market Cap
- SCNX 14.0M
- MTNB 16.1M
- IPO Year
- SCNX 2020
- MTNB N/A
- Fundamental
- Price
- SCNX $8.10
- MTNB $0.55
- Analyst Decision
- SCNX
- MTNB Hold
- Analyst Count
- SCNX 0
- MTNB 1
- Target Price
- SCNX N/A
- MTNB N/A
- AVG Volume (30 Days)
- SCNX 18.2K
- MTNB 569.5K
- Earning Date
- SCNX 11-06-2024
- MTNB 11-13-2024
- Dividend Yield
- SCNX N/A
- MTNB N/A
- EPS Growth
- SCNX N/A
- MTNB N/A
- EPS
- SCNX 3.55
- MTNB N/A
- Revenue
- SCNX N/A
- MTNB N/A
- Revenue This Year
- SCNX $1,085.75
- MTNB N/A
- Revenue Next Year
- SCNX N/A
- MTNB N/A
- P/E Ratio
- SCNX $3.46
- MTNB N/A
- Revenue Growth
- SCNX 166.67
- MTNB N/A
- 52 Week Low
- SCNX $3.69
- MTNB $0.50
- 52 Week High
- SCNX $44.56
- MTNB $21.50
- Technical
- Relative Strength Index (RSI)
- SCNX N/A
- MTNB 22.15
- Support Level
- SCNX N/A
- MTNB $0.55
- Resistance Level
- SCNX N/A
- MTNB $0.65
- Average True Range (ATR)
- SCNX 0.00
- MTNB 0.12
- MACD
- SCNX 0.00
- MTNB 0.06
- Stochastic Oscillator
- SCNX 0.00
- MTNB 4.91
About SCNX Scienture Holdings Inc. Common Stock
Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on providing value to patients and caregivers by offering novel specialty products to satisfy unmet market needs and optimize the prescription journey and patient engagement in the U.S.
About MTNB Matinas Biopharma Holdings Inc.
Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others.